NASDAQ:SYNA • US87157D1090
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SYNAPTICS INC (SYNA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-06 | Mizuho | Maintains | Outperform -> Outperform |
| 2026-02-06 | Needham | Maintains | Buy -> Buy |
| 2026-02-06 | Rosenblatt | Maintains | Buy -> Buy |
| 2026-02-06 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-01-22 | Susquehanna | Maintains | Positive -> Positive |
| 2026-01-15 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-12-29 | Northland Capital Markets | Maintains | Outperform -> Outperform |
| 2025-12-19 | Wells Fargo | Initiate | Overweight |
| 2025-12-02 | Northland Capital Markets | Initiate | Outperform |
| 2025-11-11 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-11-07 | Needham | Maintains | Buy -> Buy |
| 2025-10-17 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-09-11 | Deutsche Bank | Initiate | Buy |
| 2025-08-18 | Barclays | Initiate | Overweight |
| 2025-03-24 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-02-27 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-02-07 | Needham | Maintains | Buy -> Buy |
| 2025-02-07 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-02-04 | Needham | Reiterate | Buy -> Buy |
| 2025-02-04 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-01-29 | Needham | Reiterate | Buy -> Buy |
| 2025-01-22 | Susquehanna | Maintains | Positive -> Positive |
| 2024-11-08 | Needham | Maintains | Buy -> Buy |
| 2024-11-08 | Rosenblatt | Maintains | Buy -> Buy |
| 2024-10-31 | Rosenblatt | Maintains | Buy -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.355B -22.11% | 959.4M -29.20% | 1.074B 11.98% | 1.21B 12.63% | 1.327B 9.67% | 1.484B 11.83% | 1.55B 4.45% | |
| EBITDA YoY % growth | 324.1M -36.53% | 34.8M -89.26% | N/A 503.79% | 276.68M 31.68% | 326.12M 17.87% | 386.04M 18.37% | 393.72M 1.99% | |
| EBIT YoY % growth | 156.6M -56.87% | -74.4M -147.51% | 34.1M 145.83% | 217.07M 536.57% | 264.44M 21.82% | 322.25M 21.86% | 354.96M 10.15% | |
| Operating Margin | 11.56% | -7.75% | 3.17% | 17.94% | 19.93% | 21.71% | 22.90% | |
| EPS YoY % growth | 8.10 -40.27% | 2.26 -72.10% | 3.64 61.06% | 4.52 24.31% | 5.27 16.54% | 6.30 19.40% | 6.93 10.00% |
All data in USD
| Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.03 14.49% | 1.14 13.23% | 1.29 18.61% | 1.42 17.47% | 1.27 23.21% | 1.44 25.59% | 1.48 14.26% | 1.56 9.85% | 1.49 17.35% | 1.58 10.08% |
| Revenue Q2Q % growth | 295.54M 10.86% | 308.49M 9.08% | 323.99M 10.77% | 338.33M 11.84% | 325.89M 10.27% | 342.54M 11.04% | 351.92M 8.62% | 363.95M 7.57% | 357.3M 9.64% | 369.72M 7.93% |
| EBITDA Q2Q % growth | 64.158M -28.71% | 69.462M 26.11% | 79.186M 259.94% | 86.7M 25.11% | 82.042M 27.87% | 85.918M 23.69% | 90.712M 14.56% | 95.234M 9.84% | 91.562M 11.60% | 95.234M 10.84% |
| EBIT Q2Q % growth | 50.018M 516.82% | 55.414M 739.61% | 62.077M 399.89% | 67.58M 550.53% | 62.546M 25.05% | 70.145M 26.58% | 74.486M 19.99% | 78.719M 16.48% | 76.041M 21.58% | 79.815M 13.79% |
All data in USD
20 analysts have analysed SYNA and the average price target is 104.45 USD. This implies a price increase of 45.07% is expected in the next year compared to the current price of 72.
SYNAPTICS INC (SYNA) will report earnings on 2026-05-06, after the market close.
The consensus EPS estimate for the next earnings of SYNAPTICS INC (SYNA) is 1.03 USD and the consensus revenue estimate is 295.54M USD.
The number of analysts covering SYNAPTICS INC (SYNA) is 20.